1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Trial status changed: Enrolling by Invitation → Completed
Also in this update: Final enrollment: 918 participants (planned 1200); Primary completion date changed from estimate of Dec 31, 2025 to Mar 27, 2024
Huahui HealthPhase 3 NCT05787418 Registry history of NCT05787418 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-15 | NCT07876440 A Clinical Study of HH-1270 in Healthy Chinese Subjects | Phase 1 | Not Yet Recruiting |
| Phase 1 | 2 | |
| Phase 1/2 | 1 | |
| Phase 2 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07499544 | A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With… | Chronic Hepatitis D Infection | Recruiting | 2026-08-24 |
| Phase 2 | ||||
| NCT07519330 | Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic… | Chronic Hepatitis B Virus Infection | Recruiting | 2026-06-15 |
| Phase 1/2 | ||||
| NCT07547553 | A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of… | Advanced or Unresectable Hepatocellular Carcinoma (HCC) | Recruiting | 2026-06-16 |
| Phase 1 | ||||
| NCT07623369 | A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors | Solid Tumor | Recruiting | 2026-08-21 |
| NCT07876440 | A Clinical Study of HH-1270 in Healthy Chinese Subjects | Chronic HDV Infection | Not Yet Recruiting | 2026-10-15 |
Liver Cancer (2) · Bladder Cancer (1) · Breast Cancer (1) · Cervical Cancer (1) · Colorectal Cancer (1) · Endometrial Cancer (1) · Esophageal Cancer (1) · Head & Neck Cancer (1) · Kidney Cancer (1) · Lung Cancer (1)